However, BCP inhibited non-small cell lung cancer (NSCLC) growth via dysregulating the antioxidant enzymes (SOD, CAT and GPx) and ROS, and increasing apoptotic factors (cleaved caspase-3 and Bax) in these cells [20]. This evidence concerns the gene CAT and non-small cell lung carcinoma.